1. Home
  2. RGEN vs CAVA Comparison

RGEN vs CAVA Comparison

Compare RGEN & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$173.82

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$67.50

Market Cap

6.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
CAVA
Founded
1981
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
6.8B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
RGEN
CAVA
Price
$173.82
$67.50
Analyst Decision
Buy
Buy
Analyst Count
10
19
Target Price
$174.90
$78.58
AVG Volume (30 Days)
550.6K
3.4M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
151.16
EPS
0.03
1.16
Revenue
$707,890,000.00
$1,132,074,000.00
Revenue This Year
$17.84
$24.00
Revenue Next Year
$12.44
$20.42
P/E Ratio
$6,658.81
$54.75
Revenue Growth
11.74
23.93
52 Week Low
$102.97
$43.41
52 Week High
$182.52
$144.49

Technical Indicators

Market Signals
Indicator
RGEN
CAVA
Relative Strength Index (RSI) 66.62 76.24
Support Level $162.21 $58.05
Resistance Level $167.65 $62.16
Average True Range (ATR) 4.82 2.33
MACD 0.56 0.91
Stochastic Oscillator 89.52 98.15

Price Performance

Historical Comparison
RGEN
CAVA

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.

Share on Social Networks: